Virginie Magnone
Centre national de la recherche scientifique
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Virginie Magnone.
Comparative and Functional Genomics | 2003
Manal A. Dayem; Chimène Moreilhon; Laurent Turchi; Virginie Magnone; Richard Christen; Gilles Ponzio; Pascal Barbry
Wound healing involves several steps: spreading of the cells, migration and proliferation. We have profiled gene expression during the early events of wound healing in normal human keratinocytes with a home-made DNA microarray containing about 1000 relevant human probes. An original wounding machine was used, that allows the wounding of up to 40% of the surface of a confluent monolayer of cultured cells grown on a Petri dish (compared with 5% with a classical ‘scratch’ method). The two aims of the present study were: (a) to validate a limited number of genes by comparing the expression levels obtained with this technique with those found in the literature; (b) to combine the use of the wounding machine with DNA microarray analysis for large-scale detection of the molecular events triggered during the early stages of the wound-healing process. The time-courses of RNA expression observed at 0.5, 1.5, 3, 6 and 15 h after wounding for genes such as c-Fos, c-Jun, Egr1, the plasminogen activator PLAU (uPA) and the signal transducer and transcription activator STAT3, were consistent with previously published data. This suggests that our methodologies are able to perform quantitative measurement of gene expression. Transcripts encoding two zinc finger proteins, ZFP36 and ZNF161, and the tumour necrosis factor α-induced protein TNFAIP3, were also overexpressed after wounding. The role of the p38 mitogen-activated protein kinase (p38MAPK) in wound healing was shown after the inhibition of p38 by SB203580, but our results also suggest the existence of surrogate activating pathways.
New Phytologist | 2017
Clémence Medina; Martine Da Rocha; Marc Magliano; Alizée Ratpopoulo; Benoît Revel; Nathalie Marteu; Virginie Magnone; Kevin Lebrigand; Javier Cabrera; Marta Barcala; Ana Cláudia Silva; Anthony A. Millar; Carolina Escobar; Pierre Abad; Bruno Favery; Stéphanie Jaubert-Possamai
Root knot nematodes (RKN) are root parasites that induce the genetic reprogramming of vascular cells into giant feeding cells and the development of root galls. MicroRNAs (miRNAs) regulate gene expression during development and plant responses to various stresses. Disruption of post-transcriptional gene silencing in Arabidopsis ago1 or ago2 mutants decrease the infection rate of RKN suggesting a role for this mechanism in the plant-nematode interaction. By sequencing small RNAs from uninfected Arabidopsis roots and from galls 7 and 14xa0d post infection with Meloidogyne incognita, we identified 24 miRNAs differentially expressed in gall as putative regulators of gall development. Moreover, strong activity within galls was detected for five miRNA promoters. Analyses of nematode development in an Arabidopsis miR159abc mutant had a lower susceptibility to RKN, suggesting a role for the miR159 family in the plant response to M.xa0incognita. Localization of mature miR159 within the giant and surrounding cells suggested a role in giant cell and gall. Finally, overexpression of miR159 in galls at 14xa0d post inoculation was associated with the repression of the miR159 target MYB33 which expression is restricted to the early stages of infection. Overall, these results implicate the miR159 in plant responses to RKN.
FEBS Letters | 2017
Olivier Mercey; Alexandra Popa; Amélie Cavard; Agnès Paquet; Benoit Chevalier; Nicolas Pons; Virginie Magnone; Joséphine Zangari; Patrick Brest; Laure-Emmanuelle Zaragosi; Gilles Ponzio; Kevin Lebrigand; Pascal Barbry; Brice Marcet
miR‐34/449 microRNAs are conserved regulators of multiciliated cell differentiation. Here, we evidence and characterize expression of two isomiR variant sequences from the miR‐34/449 family in human airway epithelial cells. These isomiRs differ from their canonical counterparts miR‐34b and miR‐449c by one supplemental uridine at their 5′‐end, leading to a one‐base shift in their seed region. Overexpression of canonical miR‐34/449 or 5′‐isomiR‐34/449 induces distinct gene expression profiles and biological effects. However, some target transcripts and functional activities are shared by both canonical microRNAs and isomiRs. Indeed, both repress important targets that result in cell cycle blockage and Notch pathway inhibition. Our findings suggest that 5′‐isomiR‐34/449 may represent additional mechanisms by which miR‐34/449 family finely controls several pathways to drive multiciliogenesis.
Scientific Reports | 2016
Christophe Béclin; Philipp Follert; Elke Stappers; Serena Barral; Coré Nathalie; Antoine de Chevigny; Virginie Magnone; Kevin Lebrigand; Ute Bissels; Danny Huylebroeck; Andreas Bosio; Pascal Barbry; Eve Seuntjens; Harold Cremer
During neurogenesis, generation, migration and integration of the correct numbers of each neuron sub-type depends on complex molecular interactions in space and time. MicroRNAs represent a key control level allowing the flexibility and stability needed for this process. Insight into the role of this regulatory pathway in the brain is still limited. We performed a sequential experimental approach using postnatal olfactory bulb neurogenesis in mice, starting from global expression analyses to the investigation of functional interactions between defined microRNAs and their targets. Deep sequencing of small RNAs extracted from defined compartments of the postnatal neurogenic system demonstrated that the miR-200 family is specifically induced during late neuronal differentiation stages. Using in vivo strategies we interfered with the entire miR-200 family in loss- and gain-of-function settings, showing a role of miR-200 in neuronal maturation. This function is mediated by targeting the transcription factor Zeb2. Interestingly, so far functional interaction between miR-200 and Zeb2 has been exclusively reported in cancer or cultured stem cells. Our data demonstrate that this regulatory interaction is also active during normal neurogenesis.
Journal of Biological Chemistry | 2017
Gilles Ponzio; Roger Rezzonico; Isabelle Bourget; Richard Allan; Nicolas Nottet; Alexandra Popa; Virginie Magnone; Géraldine Rios; Bernard Mari; Pascal Barbry
Keratinocyte-derived cutaneous squamous cell carcinoma (cSCC) is the most common metastatic skin cancer. Although some of the early events involved in this pathology have been identified, the subsequent steps leading to tumor development are poorly defined. We demonstrate here that the development of mouse tumors induced by the concomitant application of a carcinogen and a tumor promoter (7,12-dimethylbenz[a]anthracene (DMBA) and 12-O-tetradecanoylphorbol-13-acetate (TPA), respectively) is associated with the up-regulation of a previously uncharacterized long noncoding RNA (lncRNA), termed AK144841. We found that AK144841 expression was absent from normal skin and was specifically stimulated in tumors and highly tumorigenic cells. We also found that AK144841 exists in two variants, one consisting of a large 2-kb transcript composed of four exons and one consisting of a 1.8-kb transcript lacking the second exon. Gain- and loss-of-function studies indicated that AK144841 mainly inhibited gene expression, specifically down-regulating the expression of genes of the late cornified envelope-1 (Lce1) family involved in epidermal terminal differentiation and of anticancer genes such as Cgref1, Brsk1, Basp1, Dusp5, Btg2, Anpep, Dhrs9, Stfa2, Tpm1, SerpinB2, Cpa4, Crct1, Cryab, Il24, Csf2, and Rgs16. Interestingly, the lack of the second exon significantly decreased AK144841s inhibitory effect on gene expression. We also noted that high AK144841 expression correlated with a low expression of the aforementioned genes and with the tumorigenic potential of cell lines. These findings suggest that AK144841 could contribute to the dedifferentiation program of tumor-forming keratinocytes and to molecular cascades leading to tumor development.
European Respiratory Journal | 2018
Lisa Giovannini-Chami; Agnès Paquet; Céline Sanfiorenzo; Nicolas Pons; Julie Cazareth; Virginie Magnone; Kevin Lebrigand; Benoit Chevalier; Ambre Vallauri; Valérie Julia; Charles-Hugo Marquette; Brice Marcet; Sylvie Leroy; Pascal Barbry
In line with the pathophysiological continuum described between nose and bronchus in allergic respiratory diseases, we assessed whether nasal epithelium could mirror the Type 2 T-helper cell (Th2) status of bronchial epithelium. Nasal and bronchial cells were collected by brushing from healthy controls (C, n=13), patients with allergic rhinitis and asthma (AR, n=12), and patients with isolated allergic rhinitis (R, n=14). Cellular composition was assessed by flow cytometry, gene expression was analysed by RNA sequencing and Th2, Type 17 T-helper cell (Th17) and interferon (IFN) signatures were derived from the literature. Infiltration by polymorphonuclear neutrophils (PMN) in the nose excluded 30% of the initial cohort. All bronchial samples from the AR group were Th2-high. The gene expression profile of nasal samples from the AR group correctly predicted the paired bronchial sample Th2 status in 71% of cases. Nevertheless, nasal cells did not appear to be a reliable surrogate for the Th2 response, in particular due to a more robust influence of the IFN response in 14 out of 26 nasal samples. The Th2 scores in the nose and bronchi correlated with mast cell count (both p<0.001) and number of sensitisations (p=0.006 and 0.002), while the Th17 scores correlated with PMN count (p=0.006 and 0.003). The large variability in nasal cell composition and type of inflammation restricts its use as a surrogate for assessing bronchial Th2 inflammation in AR patients. Nasal epithelial cells are not good surrogates for bronchial epithelial cells in the evaluation of Th2 inflammation http://ow.ly/if5u30ltyx5
Scientific Reports | 2016
Christophe Béclin; Philipp Follert; Elke Stappers; Serena Barral; Nathalie Coré; Antoine de Chevigny; Virginie Magnone; Kevin Lebrigand; Ute Bissels; Danny Huylebroeck; Andreas Bosio; Pascal Barbry; Eve Seuntjens; Harold Cremer
Scientific Reports 6: Article number: 35729; published online: 21 October 2016; updated: 21 December 2016.
Journal of Biological Chemistry | 2000
Amanda Patel; François Maingret; Virginie Magnone; Michel Fosset; Michel Lazdunski; Eric Honoré
Physiological Genomics | 2005
Chimène Moreilhon; Delphine Gras; Coralie Hologne; Odile Bajolet; Virginie Magnone; Marc Merten; Hervé Groux; Edith Puchelle; Pascal Barbry
European Respiratory Journal | 2017
Lisa Giovannini-Chami; Agnès Paquet; Céline Sanfiorenzo; Nicolas Pons; Julie Cazareth; Virginie Magnone; KéVin Le Brigand; Benoit Chevalier; Valérie Julia; Sylvie Leroy; Charles-Hugo Marquette; Pascal Barbry; Brice Marcet